Effect of Metformin on Disease Progression in Patients With Cryptogenic Cirrhosis (NASH-related Cirrhosis) With Diabetes or Impaired Glucose Tolerance or Insulin Resistance

NCT02234440 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

86

Enrollment

OTHER

Sponsor class

Conditions

NASH Related Cirrhosis

Interventions

DRUG: Metformin
DRUG: Insulin

Sponsor

Institute of Liver and Biliary Sciences, India